Is Proton Therapy Suitable for Pediatric Cancer Patients? (2026 Update)

Yes, pediatric cancer is one of the classic indications for proton therapy. Because it excels at sparing a growing child's normal tissue, it is widely considered as a way to reduce the risk of growth impairment or secondary cancers.

Key Summary

• Proton therapy is a particle-based radiation treatment that accelerates hydrogen nuclei toward a tumor, delivering almost no radiation to the normal tissue lying beyond the tumor.
• A growing child's normal tissue carries a relatively higher risk of growth impairment or secondary cancer after radiation exposure, and the NCCN patient guidelines describe protecting normal tissue as an important consideration in pediatric tumors.
• When a pediatric patient is being treated, sedation may be needed to keep the child still, and in such cases a pediatric anesthesia team is present throughout.
• The total stay, including the planning stage, is typically 4 to 7 weeks, with outpatient visits five times a week for a total of 10 to 35 sessions.
• Proton therapy for pediatric cancer is a field with long-accumulated experience in Korea, and treatment takes place at tertiary hospitals equipped with international healthcare centers.

Why Is Proton Therapy Recommended for Pediatric Cancer?

• Because protons stop at a predetermined depth and release their energy intensively there (the Bragg peak), almost no radiation reaches the normal tissue located behind the tumor.
• The biological effect of killing cancer cells is similar to that of conventional X-ray radiation; the difference lies in delivering the same dose to the tumor while reducing the dose to surrounding areas.
• This difference matters especially in a growing body. Minimizing the radiation dose to normal tissue as much as possible helps lower the risk of growth impairment or secondary cancer, which is why pediatric cancer is described as a classic application for proton therapy.
• For the same reason, proton therapy is also considered when a tumor sits right next to structures that are hard to recover if damaged, such as the eyes, brain, spinal cord, or skull base.

How Does the Treatment Process Proceed?

• Step 1: Simulation imaging, fabrication of an immobilization device, and treatment planning and verification take 1 to 2 weeks.
• Step 2: Outpatient visits occur five times a week for 10 to 35 sessions in total, with each visit, including preparation, taking around 30 minutes.
• Step 3: If the child needs to stay still, sedation may be required, with a pediatric anesthesia team present. Meal and sleep schedules are arranged to allow sedation at the same time each day, and because this schedule shapes the whole family's daily routine, it is explained in advance.
• Step 4: Return to the home country is possible within a few days after the final session, and treatment response is confirmed over the following months through imaging.
• Step 5: Because pediatric patients require long-term monitoring of growth and hormonal function, a follow-up plan for handover to local medical staff is provided in writing.

What Side Effects Can Occur?

• There is no pain during irradiation; the most common reactions are fatigue and skin changes at the treated site.
• Treating the head may cause hair loss in that specific area, but hair in untreated areas is generally preserved — a notable difference from systemic chemotherapy.
• Treating the head and neck may cause mouth sores, dry mouth, or taste changes; treating the chest may cause swallowing discomfort or coughing; and treating the pelvis may cause changes in urination or bowel movements. Most of these resolve over several weeks after treatment ends.
• Since the severity and recovery speed of these reactions vary by individual, it is important to discuss specific management with the treating medical team.

FAQ — How Does This Differ From Heavy-Ion (Carbon-Ion) Therapy?

Heavy-ion therapy uses carbon ions, a form of particle radiation that is heavier than protons and causes stronger DNA breaks, making it effective even against tumors that respond poorly to conventional radiation. Neither option is universally 'better' — rather, each has its appropriate use: proton therapy is considered when protecting normal tissue is the priority, as in pediatric patients or tumors near the eyes, brain, or spinal cord, while heavy-ion therapy is considered for tumors where radiation resistance is the main concern.

FAQ — What Records Are Needed Before Treatment?

Essential materials include recent original CT/MRI scans (MRI is especially important for brain and head-and-neck cases), biopsy and pathology reports, prior radiation treatment records (site, total dose, number of fractions, dates), and surgical/chemotherapy history. For pediatric patients, it is also recommended to prepare growth records, hormone test results, developmental assessments, sedation/anesthesia history, and vaccination records.

Sources and Notes

• This article was written based on notes on proton therapy and heavy-ion therapy (National Cancer Center Korea, NCCN patient guidelines, and HiKorea materials).
• This content is provided for general medical information purposes only; diagnosis, treatment methods, and outcomes may vary depending on individual circumstances. Accurate diagnosis and treatment decisions should always be made in consultation with a medical professional.